Meta regression: Relationship between antipsychotic receptor binding profiles and side-effects.

Area of Science:

• Pharmacology
• Neuroscience
• Psychiatry

Background:

• Antipsychotic medications are crucial for schizophrenia treatment.
• Common side effects can impact patient adherence and outcomes.
• Predicting side effects based on drug properties is a clinical need.

Purpose of the Study:

• To investigate the relationship between antipsychotic receptor binding profiles and common side effects.
• To determine which specific receptor affinities are associated with weight gain, sedation, hyperprolactinemia, and extrapyramidal symptoms.

Main Methods:

• Regression analysis was used to correlate receptor binding affinities (log Ki) with side effect magnitudes.
• Data from a network meta-analysis on schizophrenia treatment was utilized.
• Affinity for D2, 5-HT1A, 5-HT2A, 5-HT2C, H1, alpha1, alpha2, M1, M3, and M4 receptors were examined.

Main Results:

• Weight gain was associated with M1, M3, 5-HT2C, and H1 receptor affinities.
• Sedation and hyperprolactinemia risks correlated with M1 and M4 receptor affinities.
• Extrapyramidal side effects were linked to 5-HT2C and M1 receptor affinities.
• QT prolongation showed no significant association with receptor affinities.

Conclusions:

• Increased antipsychotic affinity for specific receptors significantly correlates with higher risks of sedation, hyperprolactinemia, extrapyramidal side effects, and weight gain.
• This finding aids in understanding the pharmacological basis of antipsychotic side effects.
• Informing drug selection and management strategies for schizophrenia.